06.03.2013 • NewsAkzoNobelQ4 2012FY 2012

AkzoNobel Announces Q4, FY 2012 Results

AkzoNobel announced its Q4 and full-year 2012 results. Revenue for the year was up 5% driven by favorable currencies and pricing, which was partially offset by a decline in volumes. EBITDA for the year was 4% higher at €1,901 million (2011: €1,834 million) helped by the performance improvement program, which contributed €276 million to EBITDA. As a consequence of the impairment charge of €2,106 million in Q3 related to Decorative Paints, we recorded a full-year operating loss of €1,244 million. Excluding this impairment charge, operating income was €862 million positive (2011: €1,145 million).

CEO Ton Büchner

"AkzoNobel delivered a strong set of results in difficult markets, underpinned by the performance improvement program which exceeded our intermediate targets."

Commenting on the outlook Büchner said: "The economic environment remains challenging and we expect no fundamental changes in the trends that we have seen recently in our businesses. We will continue to focus on performance improvements and operational efficiencies in order to benefit from our strong portfolio of businesses with many leading market positions and exposure to growth markets."

Business performance

Decorative Paints was impacted by weaker demand in the European markets.

Specialty Chemicals delivered a robust performance, despite weaker demand in the second half of the year. Performance Coatings recorded a strong performance driven by margin management and operational efficiency actions, despite weaker volumes overall.

Portfolio changes

On December 14, 2012, AkzoNobel announced the sale of Decorative Paints North America to PPG. On December 28, 2012, the company completed the sale of Chemicals Pakistan, which was subsequently deconsolidated. In early 2012, AkzoNobel acquired Boxing Oleochemicals in

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.